|
🦁
|
Pathophysiology of Cisplatin-Induced Acute Kidney Injury
A. Ozkok,
C. Edelstein
|
9 |
2014 |
9
🦁
|
|
🐜
|
Lowering Uric Acid With Allopurinol Improves Insulin Resistance and Systemic Inflammation in Asymptomatic Hyperuricemia
16 auth.
M. Takir,
O. Kostek,
A. Ozkok,
O. Elcioglu,
A. Bakan,
Aybala Erek,
H. Mutlu,
Ozge Telci,
Aysun Semerci,
A. Odabaş,
...
B. Afşar,
G. Smits,
Miguel ALanaspa,
S. Sharma,
Richard J. Johnson,
M. Kanbay
|
7 |
2015 |
7
🐜
|
|
🐢
|
Contrast-induced acute kidney injury: A review of practical points
Sercin Ozkok,
A. Ozkok
|
6 |
2017 |
6
🐢
|
|
🦁
|
Hepatitis C virus associated glomerulopathies.
A. Ozkok,
A. Yıldız
|
6 |
2014 |
6
🦁
|
|
🦁
|
NF-κB transcriptional inhibition ameliorates cisplatin-induced acute kidney injury (AKI).
A. Ozkok,
Kameswaran Ravichandran,
Qian Wang,
D. Ljubanović,
C. Edelstein
|
6 |
2016 |
6
🦁
|
|
🦁
|
Osteoprotegerin/RANKL axis and progression of coronary artery calcification in hemodialysis patients.
8 auth.
A. Ozkok,
Y. Caliskan,
T. Şakacı,
G. Erten,
G. Karahan,
A. Ozel,
...
A. Unsal,
A. Yıldız
|
6 |
2012 |
6
🦁
|
|
🦁
|
Clinical characteristics and predictors of progression of chronic kidney disease in autosomal dominant polycystic kidney disease: a single center experience
10 auth.
A. Ozkok,
T. Akpınar,
F. Tufan,
N. Kanıtez,
M. Uysal,
M. Guzel,
...
Y. Caliskan,
S. Alişir,
H. Yazıcı,
T. Ecder
|
5 |
2013 |
5
🦁
|
|
🦁
|
FGF-23 associated with the progression of coronary artery calcification in hemodialysis patients
7 auth.
A. Ozkok,
C. Kekik,
G. Karahan,
T. Şakacı,
A. Ozel,
A. Unsal,
...
A. Yıldız
|
5 |
2013 |
5
🦁
|
|
🐜
|
Coronary artery calcification and coronary flow velocity in haemodialysis patients.
8 auth.
Y. Caliskan,
M. Demirturk,
A. Ozkok,
B. Yelken,
T. Şakacı,
H. Oflaz,
...
A. Unsal,
A. Yıldız
|
5 |
2010 |
5
🐜
|
|
🦁
|
Cholesterol-embolization syndrome: current perspectives
A. Ozkok
|
5 |
2019 |
5
🦁
|
